Xiewan Chen
Impact in
- Infectious Diseases top 1%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Neurology top 1%
- Long-Term Effects of COVID-19
Papers in
- Oncology 10
- Cancer Immunotherapy and Biomarkers 4
- Cancer Cells and Metastasis 3
-
- RNA Research and Splicing 2
- Co-authors
- Li Chen (1 shared paper)Yuzhang Wu (1 shared paper)Yongwen Chen (1 shared paper)Chenhui Wang (1 shared paper)Yueping Liu (1 shared paper)Yingjun Tan (1 shared paper)Min Li (1 shared paper)Bo Diao (1 shared paper)
- Journals
- Oncotarget (3 papers)International Journal of Molecular Medicine (2 papers)BMC Cancer (2 papers)Bioactive Materials (1 paper)BioMed Research International (1 paper)
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Xiewan Chen
25 papers receiving 2.1k citations
Xiewan Chen's Hit Papers
Peers
Comparison fields: 5 of 112
- Infectious Diseases 1.2k
- Neurology 634
- Biological Psychiatry 33
- Immunology 260
- Oncology 282
Countries citing papers authored by Xiewan Chen
This map shows the geographic impact of Xiewan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiewan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiewan Chen more than expected).
Fields of papers citing papers by Xiewan Chen
This network shows the impact of papers produced by Xiewan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiewan Chen. The network helps show where Xiewan Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiewan Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19) Hit paper breakdown → | 2020 | 1740 |
| 2 | 2019 | 62 | |
| 3 | 2016 | 56 | |
| 4 | 2016 | 36 | |
| 5 | 2015 | 35 | |
| 6 | 2016 | 35 | |
| 7 | 2019 | 27 | |
| 8 | 2019 | 26 | |
| 9 | 2015 | 14 | |
| 10 | 2016 | 11 | |
| 11 | Clinical benefits of Livin peptide-loaded DCs/CIKs combined with chemotherapy in advanced non-small cell lung cancer. | 2019 | 11 |
| 12 | 2021 | 10 | |
| 13 | 2022 | 8 | |
| 14 | 2015 | 8 | |
| 15 | 2021 | 8 | |
| 16 | 2017 | 7 | |
| 17 | 2013 | 6 | |
| 18 | 2016 | 6 | |
| 19 | 2024 | 3 | |
| 20 | 2023 | 3 |
About Xiewan Chen
Xiewan Chen is a scholar working on Oncology, Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine and Immunology, having authored 26 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (4 papers), MicroRNA in disease regulation (4 papers), Cancer Cells and Metastasis (3 papers), Lung Cancer Treatments and Mutations (3 papers), Cancer-related molecular mechanisms research (3 papers), Cancer Genomics and Diagnostics (2 papers), RNA Research and Splicing (2 papers) and Hippo pathway signaling and YAP/TAZ (2 papers). The work is most often cited by research in Infectious Diseases (1.2k citations), Neurology (634 citations), Biological Psychiatry (33 citations), Immunology (260 citations) and Oncology (282 citations). Xiewan Chen has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Li Chen, Yuzhang Wu, Yongwen Chen, Chenhui Wang, Yueping Liu, Yingjun Tan, Min Li, Bo Diao, Yi Zhang and Zeqing Feng. Their work appears in journals such as Oncotarget, International Journal of Molecular Medicine, BMC Cancer, Bioactive Materials and BioMed Research International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.